Last updated on December 25, 2025
KUALA LUMPUR, 25 November 2025 — DC Healthcare Holdings Berhad (“DC Healthcare”), a provider of non-invasive and minimally invasive medical aesthetic services, returned to profitability in the third quarter ended 30 September 2025 (Q3 FY2025), posting a Profit Before Tax (PBT) of RM3.06 million.
Revenue rose 62.7% year-on-year to RM25.72 million, driven mainly by the aesthetic segment, which contributed RM22.23 million or 86.4% of total revenue. Stronger treatment redemptions and higher cash sales collections translated into a gross profit of RM14.44 million, doubling from RM7.17 million in Q3 FY2024.
The earnings turnaround reflects improved operating leverage, clearer demand visibility and disciplined cost management. PBT of RM3.06 million marks a sharp reversal from the Loss Before Tax (LBT) of RM2.15 million recorded a year ago.
9M FY2025: Revenue Rises 64.1%, PBT Recovers Sharply
For the nine months ended 30 September 2025 (9M FY2025), DC Healthcare recorded cumulative revenue of RM64.22 million, up from RM39.14 million in 9M FY2024. The aesthetic segment continued to anchor growth, rising to RM54.89 million from RM32.16 million previously.
The Group also achieved a PBT of RM1.19 million, compared with a LBT of RM16.77 million in 9M FY2024, underscoring substantial margin recovery and operational improvements.
Sequential Momentum: Revenue Up 24.9%, Swing Back to Profit
Quarter-on-quarter, revenue climbed 24.9% from RM20.60 million in Q2 FY2025. DC Healthcare also swung from a LBT of RM1.03 million in Q2 FY2025 to a PBT of RM3.06 million in Q3 FY2025, supported by increased aesthetic redemptions and the Group-wide efficiency and cost optimisation programme.
Managing Director: Return to Profit Marks a Key Milestone
Managing Director Dr. Chong Tze Sheng said:
“Q3 marks an important milestone for DC Healthcare as we return to profitability ahead of expectations. The strong performance reflects the solid demand for our aesthetic services, the resilience of our operating model, and the progress of our efficiency programme.”
He added that the Group will continue strengthening its brand ecosystem, investing in technology and maintaining disciplined cost management to support future growth.
Strategic Focus: Brand Integration, AI Adoption and Cost Efficiency
DC Healthcare said it remains focused on several long-term initiatives, including:
- Synergising its core brands: Dr. Chong Clinic, Dr. Chong Slimming, and NewB Premium Skincare
- Expanding skincare product offerings to drive higher customer engagement
- Adopting AI-assisted skin analysis and personalised treatment planning to enhance precision and patient experience
- Continuing the Group-wide efficiency programme to reduce wastage and improve cost control
The Group also highlighted that its RM8.0 million property acquisition in Bandar Kinrara, Puchong will help reduce reliance on leased premises and optimise long-term operating costs.
With these measures in place, DC Healthcare said it is well-positioned to sustain its recovery momentum and capture the growing opportunities in Malaysia’s aesthetic and wellness sector.
